(Total Views: 502)
Posted On: 05/25/2022 10:04:43 PM
Post# of 154867
Quote:
[1] GBM is not listed in the 90 LL indications on this board
I never listed individual cancers.
Quote:
CCR5 is highly expressed in glioblastoma and is associated with poor prognosis of patients. CCL5/CCR5 is suggested to be an excellent new target for glioblastoma therapy.
Clinical trials have recently opened targeting CCR5 using a humanized monoclonal antibody (leronlimab) for metastatic triple negative breast cancer (TNBC)
Cytokine CCL5 and Receptor CCR5 Axis in Glioblastoma Multiforme
(3)
(0)
